|
1 |
Time to Loss of Disease Control following Guselkumab Withdrawal in Relation to Initial Speed of Response: A post hoc Analysis of the VOYAGE 2 Trial
Enthalten in Dermatology Bd. 241, 2025, Nr. 2: 133-142. 10 S.
|
|
|
|
2 |
Does Improvement of Glycemic Control Cause Acute Charcot Foot in Patients with Diabetes?
Enthalten in Experimental and clinical endocrinology & diabetes Bd. 133, 2025, Nr. 03: 120-132
|
|
|
|
3 |
The Role of Infant Gut Microbiota Modulation by Perinatal Maternal Probiotic Intervention in Atopic Eczema Risk Reduction
Enthalten in Neonatology Bd. 122, 2025, Nr. 1: 84-94. 11 S.
|
|
|
|
4 |
Preliminary Efficacy, Tolerability, and Safety Analysis of Darolutamide for Metastatic Castration-Resistant Prostate Cancer: A Single-Center, Open-Label Study
Enthalten in Urologia internationalis Bd. 109, 2025, Nr. 2: 167-174. 8 S.
|
|
|
|
5 |
Unterschiedlich ausgeprägte Placebo-Effekte bei psychischen Erkrankungen
Enthalten in Fortschritte der Neurologie, Psychiatrie Bd. 93, 2025, Nr. 04: 119-119
|
|
|
|
6 |
Effectiveness of Transcranial Direct Current Stimulation in Treating Drug-Resistant Focal Epilepsy: A Systematic Review and Meta-Analysis
Enthalten in European neurology Bd. 88, 2025, Nr. 1: 18-27. 10 S.
|
|
|
|
7 |
Efficacy and Safety of Fibroblast Growth Factor 21 Analogues for Metabolic Dysfunction-Associated Steatohepatitis: A Systematic Review and Meta-Analysis
Enthalten in Annals of nutrition & metabolism Bd. 81, 2025, Nr. 1: 51-60. 10 S.
|
|
|
|
8 |
What does cancer screening have to do with tomato growing?
Enthalten in Clinical chemistry and laboratory medicine Bd. 63, 2025, Nr. 7: 1286-1291. 06 S.
|
|
|
|
9 |
Adjuvante Therapie des Hochrisiko-Urothelkarzinom von Blase oder oberem Harntrakt nach radikaler Resektion
Enthalten in Aktuelle Urologie Bd. 56, 2025, Nr. 02: 128-129
|
|
|
|
10 |
Phosphorus Restriction Prevents Rapamycin-Induced Kidney Damage in Rats
Enthalten in American journal of nephrology Bd. 56, 2025, Nr. 1: 48-57. 10 S.
|
|
Administration
